Drug Approval | January 11, 2024
Unichem receives ANDA approval for Doxazosin Tablets
Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure
Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure
SyntheticGestalt will develop a pre-trained AI model to discover synthesizable drug-like hit candidates
Bromfenac Ophthalmic Solution, 0.07% is the generic equivalent of Prolensa Ophthalmic Solution, 0.07%, of Bausch & Lomb
Acquisition expands GSK’s respiratory pipeline adding AIO-001, a phase II-ready, long-acting antibody targeting the clinically validated TSLP pathway
This investment will be made by Caplin Point Laboratories Limited and its subsidiaries - Caplin Steriles Limited and Caplin One Labs Limited
Arco Lab now holds a 50% stake in Neviton
Lays Foundation Stone of 6 new facilities at AIIMS Bhopal and inaugurates a slew of facilities in Madhya Pradesh
This agreement includes upfront and milestone payments with a combined potential value of over $500m and sales royalties.
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
Dapagliflozin and Saxagliptin Tablets (RLD Qtern) had estimated annual sales of US $5 million in the US
Subscribe To Our Newsletter & Stay Updated
